TP53 and cancer: The viral oncoproteins E6 and E7 are not merely pathogenic agents that inactivate cancer suppressors such as p53 and pRb; they act as central orchestrators of a broad transcriptional and epigenetic reprogramming effort that redefines the host cellular environment to favor viral persistence and replication.